Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis in a Chinese population: A meta-analysis

Rheumatology International

Volumn 32, Issue 10, 2012, Pages 3201-3218

  Gao, Fei ^a   Ren, Lei ^a   Zhang, Cai Qin ^a   Mu, Feng Yun ^a   You, Yan Qiu ^a   Liu, Yan Hong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti cyclic citrullinated peptide antibody; Meta analysis; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ARTICLE; CHINESE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; HUMAN; MEDLINE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84867902044     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2153-y     Document Type: Article

References (147)

1. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903-911
2. Zang JW (2005) Recent advance in autoimmune diseases study. Accompl Appl 20(3):208-210
3. Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D et al (2008) Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol 35(7):1256-1264
4. Kiely PD, Brown AK, Edwards CJ, O'Reilly DT, OstÖr AJ, Quinn M et al (2009) Contemporary treatment principles for early rheumatoid arthritis: a consensus statement. Rheumatology(Oxford) 48(7):765-772
5. Zendman AJ, van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology(Oxford) 45(1):20-25
6. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64(12):1731-1736
7. EI-Gabalawy HS, Wilkins JA (2004) Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis. Arthr Res Ther 6(2):86-89
8. Bläss S, Meier C, Vohr HW, Schwochau M, Specker C, Burmester GR (1998) The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis 57(4):220-225
9. Lackner KJ, Schlosser U, Lang B, Schmitz G (1998) Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br J Rheumatol 37(11):1164-1171
10. Matsumoto I, Lee DM, Goldbach-Mansky R, Sumida T, Hitchon CA, Schur PH et al (2003) Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthr Rheum 48(4):944-954
11. Nienhuis RL, Mandema E (1964) A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Ann Rheum Dis 23:302-305
12. Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J 2(6182):97-99
13. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthr Rheum 43(1):155-163
14. Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC et al (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120(8):667-676
15. Devillé WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31(3):315-324
17. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25
18. Lantz CA, Nebenzahl E (1996) Behavior and interpretation of the kappa statistic: resolution of the two paradoxes. J Clin Epidemiol 49(4):431-434
19. Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F (2003) A likelihood ratio approach to meta-analysis of diagnostic studies. J Med Screen 10(1):47-51
20. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129-1135
21. Gatsonis C, Paliwal P (2006) Meta-analysis of diagnostic and screening test accuracy evaluation: methodologic primer. AJR Am J Roentgenol 187(2):271-281
22. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM Jr (2003) Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 3(10):633-643
23. Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323(7305):157-162
24. Petitti DB (2001) Approaches to heterogeneity in meta-analysis. Statist Med 20(23):3625-3633
25. Song F, Khan KS, Dinnes J, Sutton AJ (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31(1):88-95
26. Gu YL, Chen YM, Lv L, Xu ML (2004) Study on the anti-cyclic citrullinated peptide antibodies and the rheumatoid factors in the diagnosis of rheumatoid arthritis. J Diagn Concepts Pract 3(4):254-256
27. Wang YQ, Sun JH, Zhang T, Wang FD, Xu PR, Zhao YT (2005) Diagnostic value of anti-cyclic citrullinated peptide antibody detected by ELISA in patients with rheumatoid arthritis. Acta Univ Med Nanjing (Nat Sci) 25(3):215-216
28. Wang YL, Hu JF, Liu YM, Nie L (2006) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Pract Clin Med 7(6):36-39
29. Xu ZY, Zhao SP, Wu MH, Lin LR, Yu XR (2005) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Chin J Rheumatol 9(11):700-701
30. Wu SH, Chen G, Jin Q, Zhang WY (2005) Diagnostic value of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in patients with rheumatoid arthritis. Zhejiang Pract Med 10(6):381-405
31. Qin BR, Wang YQ (2007) Diagnostic value of serum anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Mod Prev Med 34(2):346-348
32. Lu SJ, Shao J, Jiang QX (2005) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Shanxi Med J 34(7):585-586
33. Wang DT, Chen L, Wang YR (2007) The diagnostic value of anti-cyclic citrullinated peptide antibody and anti-keratin antibody in patients with rheumatoid arthritis. Inner Mongolia Med J 39(7):797-798
34. Chen JW, Li XF, Ru JL, Hu XF (2007) Significance of anti-citrullinated peptide antibodies in patients with rheumatic diseases. Med Forums Basic 11(8):688-689
35. Wang Y, Shi J, Cheng W (2003) The diagnostic significance of anti-RA33 and anti-CCP in rheumatoid arthritis. Chongqing Med 32(8):1033-1034
36. Yang YQ, Zhang YM, Tang ZG (2008) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Lab Med Clin 5(6):343-344
37. Cui HD, Zhang N, Fu HX, Liu XK, Yang LL, Xue HX et al (2006) The detection value of anti- cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Chin J Pract Intern Med 26(24):1977-1978
38. Sun T, Zhu J, Ning F, Liu QJ (2008) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Anhui Health Voc Tech College 7(5):34-37
39. Zhu XH, Peng JH (2009) Diagnostic value of anti-cyclic citrullinated peptide antibody and rheumatoid factor in rheumatoid arthritis. Clin J Med Off 37(6):1041-1042
40. Zhong LY, Li RY, Zeng ZH (2004) The diagnostic value of anti-cyclic citrullinated peptide antibody and anti-RA33 antibody performed concomitantly with RF in patients with rheumatoid arthritis. Proc Clin Med 13(8):568-570
41. Dai CC, Dai L, Zheng DH (2005) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Guangdong Med J 26(6):796-797
42. Yan LW, Li J, Wu L, Zhang ML (2007) Diagnostic significance of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Jiangsu Univ (Med Ed) 17(2):165-166
43. Lei XM, Li SX (2005) Diagnosis value of anti-CCP, anti-RA33 and RF in rheumatoid arthritis. J Clin Intern Med 22(10):667-668
44. Pan XP, Xie W, Wu M, Zhang H (2006) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with early rheumatoid arthritis. Jinagsu Med J 32(1):68-69
45. Bi XF, Zhu JH, Wang CH (2009) Evaluation of anti-cyclic citrullinated peptides in diagnosing rheumatoid Arthritis. J Diseasea Monit Control 3(4):207-208
46. Yuan Y, Qing YF, Qi J, Jiang H, Wang XR (2008) The clinical value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Sichuan J Anat 16(4):5-7
47. Wang CY, Hu XZ, Zhang HX (2008) Diagnosis value of anti-CCP and anti-RA33 in rheumatoid arthritis. Shangdong Med J 48(20):84-85
48. Yi MZ, Zhang J, Yu H (2009) Diagnostic value of anti-cyclic peptide citrullinated antiboby, anti-Sa antibody, and rheumatoid factor in patients with rheumatoid arthritis. Pract Prev Med 16(4):1212-1214
49. Fan YY, Yu J (2009) Diagnostic significance of combined detection of serum anti-cyclic citrullinated peptide antibody and rheumatoid factor in rheumatoid arthritis. Lab Med Clin 6(18):1528-1529
50. Li X (2009) Diagnostic value of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in patients with rheumatoid arthritis. Guangxi Med J 31(4):515-516
51. Wei W, Qian YQ, Hou YQ (2007) The clinical value of combined detection antibodies in the early diagnosis of rheumatoid arthritis. Guizhou Med J 31(5):401-403
52. Wang Y, Jian S (2008) Comparative analysis of three autoantibodies in patients with rheumatoid arthritis. China Pract Med 3(15):130
53. Yang JJ, Gong Y, Zu H (2009) The clinical value of the combination of anti-cyclic citrullinated peptide antibody, anti-keratin and rheumatoid factor in patients with rheumatoid arthritis. J Ningxia Med Univ 31(1):43-46
54. Fan ZQ, Shi LH, Li YS (2007) Diagnostic value of anti-CCP in rheumatoid arthritis. Jilin Med J 28(17):1906-1907
55. Wang J, Li XM, Zhao HY (2009) Diagnostic value of combined detection of glucose phosphate isomerase, anti-cyclic citrullinated peptide antibody, and rheumatoid factor in patients with rheumatoid arthritis. Proc Clin Med J 18(8):581-583
56. Xiao Z, Bai LJ, Qin YQ (2005) The meaning of diagnosis and condition valuation of AFA, anti-CCP antibody and RF to rheumatoid arthritis. Acta Academiae Medicinae Mongolia 27(4):265-270
57. Bao QC (2008) Diagnostic value of level of anti-cyclic peptide citrullinated antibody, anti-keratin antibody, and rheumatoid factor in patients with rheumatoid arthritis. Inner Mongolia Med J 40(3):323-325
58. Wang J, Wang Y, Guo XX (2010) Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. China Foreign Med Treat 8:31
59. Dong W, Zhang JB, Hu X, Jun F, Zhou B (2005) Determination of anti-cyclic citrullinated peptide antibody for the diagnosis of rheumatoid arthritis. Pract J Clin Med 2(1):84-86
60. Zhang LF, Yan YG, Huang QC, Zhong Q (2004) Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Immunol J 20(1):52-57
61. Cui TP, Xie JL, Yu LK, Hu LH, Shen JL, Wu JM (2003) Diagnostic value of four autoantibodies in patients with rheumatoid arthritis. Shanghai J Med Lab Sci 18(4):221-222
62. Liu XY, Xie MY, Huang J, Wang H (2010) Diagnostic value of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in patients with rheumatoid arthritis. J Hubei Univ Chin Med 12(1):47-48
63. Wei H, Li XF, Hu XF, Xu K, Yang XY (2003) Diagnostic value of combined detection of anti-cyclic citrullinated peptide antibody and anti-Sa antibody in patients with rheumatoid arthritis. Chin J Rheumatol 7(10):635-637
64. Zhang H, Ye ZX, Liu GX XUZH, Liu Q (2004) Diagnostic value of combined detection of rheumatoid factors, anti-RA33, and anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Guizhou Med J 28(1):44-45
65. Gu FR, Zhang YD, Shi JJ (2007) Diagnosis value of anti-CCP antibody, anti-RA33 antibody, anti-Sa antibody, and RF in rheumatoid arthritis. Jiangxi J Med Lab Sci 25(1):24-34
66. Tao CH, Cai L, Ai Y, Cheng M (2009) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Youjiang Med Univ Nat 2:201-202
67. Zhang JM, Zhuo SX, Lin YP, Li Y (2009) Diagnostic value of combined detection of rheumatoid factors, anti-AKA, and anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Guangdong Med College 27(2):151-153
68. Peng XD, Li LX, Bai YJ, Zhang RW, Liu GJ (2006) Diagnostic value of anti-CCP, anti-AKA, and RF in rheumatoid arthritis. J Sichuan Univ (Med Sci Ed) 37(2):317-318
69. Liu XD, Fu HX, Cui HD, Pan LL (2009) Detection value of anti-cyclic citrullinated peptide antibody in early diagnosis in patients with rheumatoid arthritis. Pract Pharm Clin Rem 12(1):18-20
70. Huang Y, Wu YA, Ma XN, Wang SW (2004) Application and clinical value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Fujian Med Univ 38(3):337-338
71. Chen YJ, Wang X, Fan CL, Cao HJ, Chen J, Liu CL (2005) Application of measurements of serum anti-CCP and anti-RA33 in rheumatoid arthritis. J Postgrad Med 28(3):22-24
72. Wang H, Wu XH, Zhang ZY (2009) Diagnostic value of anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis. Chin J Trauma Disabil Med 17(5):15-16
73. Xie QB, Yin G (2009) Predictive values of anti-cyclic citrullinated peptide antibody, anti-keratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis. J Sichuan Univ (Med Sci Ed) 40(3):508-512
74. Yu W, Zhu MY, Shen HY, Zhang W (2006) Comparison of the value of anti-cyclic citrullinated peptides, rheumatoid factor, and anti-keratin antibody in the diagnosis for rheumatoid arthritis. Lab Med 21(2):103-105
75. Wen AQ, Wang J, Yang YS, Chen W, Zhang ZC, Liu CY (2008) Application of anti-citrullinated peptides and related auto-antibodies in diagnosing rheumatoid arthritis. Chongqing Med 37(3):262-265
76. Mu CX (2007) The clinic value of combined test of RF, AKA, and anti-CCP antibody in diagnosing rheumatoid arthritis. J Med Theor Pract 20(5):517-518
77. Lu H, Xia Y, Zhou W, Chen YE (2009) Application of joint detection of four serum indicators in diagnosis of rheumatoid arthritis. China Trop Med 9(1):72-73
78. Liang JQ, Luo YF (2006) Evaluation of indicators of early rheumatoid arthritis. J Pract Med 22(15):1820-1821
79. Chen HL, Yong WD, Han JY (2007) Combination detection of serum anti-cyclic citrullinated peptide antibody and rheumatid factor: its diagnostic value of rheumatoid arthritis. Med J Qilu 22(6):508-511
80. Sun HY, Wang CY, Liu W, Wu B, Chen LY, Chen MQ (2008) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Fujian Med Univ 42(3):284-285
81. Lin L, Xiao ZY, Chen SB, Huang SB, Xie SH (2006) Diagnostic significance of anti-cyclic citrullinated peptide antibody and its predictive value for radiological progression in patients with rheumatoid arthritis. Chin J Health Lab Technol 16(5):516-519
82. Chen HM, Sun MZ, Gu J (2007) Application of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in diagnosis of rheumatoid arthritis. J Mod Lab Med 22(4):79-80
83. Liu ZH, Ge XJ, Zhu HL (2009) Diagnosis values of combined determination of serum rheumatoid factor, C reaction protein and anti-CCP antibody in patients with rheumatoid arthritis. Mod J Integrat Trad Chin West Med 18(27):3272-3283
84. Wang Y, Fang YF, Zhong B (2004) Significance of anti-cyclic citrullinase peptide antibody and rheumatoid factor in the diagnosis of rheumatoid arthritis. Chin J Clin Rehabil 8(9):1616-1617
85. Fu KY, Chen R, Zhan F, Zhong L (2007) Value of detection of anti-CCP and rheumatoid factors AKA in diagnosis of rheumatoid arthritis. China Trop Med 7(11):2029-2030
86. Li FJ, Guo XJ, Zhao Y, Zhang J, Ding MR, Li QR (2005) Application of joint detection of four antibodies in diagnosis of early rheumatoid arthritis. Clin Focus 20(14):821-822
87. Cai F, Li L, Tang YP (2009) Clinical application of domestic anti-CCP antibody kit. J Radioimmunol 22(4):422-423
88. Chen XL, Pan SL, Gao ZF (2006) Application of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in diagnosis of rheumatoid arthritis. Sichuan Med J 27(7):690-691
89. Li SS, Bao HY (2007) Clinical diagnosis value of citrullinated protein antibodies for rheumatoid arthritis. J Med Forum 28(2):42-43
90. Meng QS, Liu XX, Ye Y, Lin MQ (2006) Clinical value of APF, AKA, RF and anti-CCP antibody in diagnosis and differential diagnosis of rheumatoid arthritis. Med Lab Sci Clin 17(6):35-37
91. Zeng ZH, Zhong LY, Li RY, Ding CP (2006) The diagnostic value of anticyclic citrullinated peptide antibody performed concomitantly with RF in patients with rheumatoid arthritis. Guangzhou Med J 36(2):64-66
92. Gao LX, Liu FZ, Liu XL (2004) The clinical significance fo anti-cyclic citrullinated polypeptide antibody and the analysis of interference factors. Chin J Diffic Compl Cas 3(4):209-211
93. Qian L, Li XP, Li XM, Wang GS, Tao JH, Zhang H et al (2004) The diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Anhui Med J 25(3):171-173
94. Xu ZY, Dai Y, Zhang DY, Zhang J (2005) Diagnostic value of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in patients with rheumatoid arthritis. Acta Academiae Medicinae Wannan 24(3):218-219
95. Xie W, Pan JP (2005) The clinical significance of anti-CCP antibody, AKA, RF in rheumatoid arthritis. Clin Focus 20(5):287-289
96. Zhao LW, Wu J, Zhang BX (2007) To exam the anti-cyclic citrullinated peptide antibody, anti-keratin antibody and antiperinuclear factor and to evaluate the diagnosis method of the early patients with rheumatoid arthritis. Med Lab Sci Clin 18(4):24-26
97. Lai ZF, Wu XN, Jiang JQ (2006) Diagnostic value of quantitative detection of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Guangxi Med Univ 23(6):985-986
98. Cai WH, Sun BD, Hong XP, Liu DZ, Tan YH, Xiao XL (2006) Evaluation of rheumatoid factor, anti-cyclic citrullinated peptide antibody and anti-keratin antibody in patients with rheumatoid arthritis. J Clin Exp Med 5(6):671-673
99. Xia QF, Qin X, Qian SJ, Wu XP (2003) The diagnostic value of anti-cyclic citrullinated peptide antibody for the patients with rheumatoid arthritis. J Hainan Med College 9(6):331-333
100. Zhou B, Zhu J, Liu J, Long WB, Wu D, Chen J et al (2004) The diagnostic and prognostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Chin J Rheumatol 8(6):360-362
101. Zeng Y, Chen M, Cai MZ, Liu Q, Gu YL, Wang KZ (2006) The diagnostic value of combinate determination of anti-cyclic citrullinated peptide antibody and rheumatoid factor for the rheumatoid arthritis. Clin Med J China 13(6):1022-1023
102. Yang CM, Wang HM, Cong H, Cao LH (2005) Diagnostic value of anti-cyclic citrullinated peptide antibody quantitative analysis in patients with rheumatoid arthritis. Jiangxi J Med Lab Sci 23(1):7-8
103. Wang J, Wen AQ, Yang YS, Zhuang SB (2007) Clinical evaluation of anti-cyclic citrullinated peptides in diagnosing rheumatoid arthritis. Chongqing Med 36(15):1513-1515
104. Ding ZM (2008) Examine the diagnostic significance by the detection anti-cyclic citrullinated peptide antibody and rheumatoid factor. Med Lab Sci Clin 19(1):38-39
105. Hu Y, Wang J, Wang QX (2008) The diagnostic value of anti-cyclic citrullinated peptide antibody and rheumatoid factor for the rheumatoid arthritis. Central China Med J 32(1):31-32
106. Chen PF, Liu YR, Chen C, Chen Q, Ye QY (2005) Clinical evaluation of early marker in diagnosing rheumatoid arthritis. Med J Wuhan Univ 26(4):529-532
107. Yu F, Fei Y, Shi P (2005) An evaluation of the diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis disease. Guizhou Med J 29(5):409-411
108. Hu XT, Xia XJ, Wei H, Jin W (2007) Diagnostic value of combined detection of anti-CCP antibody and rheumatoid factor in RA. Acta Acad Weifang 29(1):57-58
109. Song JJ, Pan XJ, Yue XH (2007) Clinical value of anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis. Occup Health 23(22):2020-2021
110. Liu Y, Yong J (2005) Evaluation of anti-cyclic citrullinated peptide antibody in diagnosing rheumatoid arthritis. J North Sichuan Med College 20(3):327-329
111. Wu CY, Huang LY, Li YM, Lin J, Li YY, Pan ZX (2009) Application of anti-cyclic citrullinated peptide in diagnosis of rheumatoid arthritis. China Trop Med 9(9):1907-1908
112. Ji CM (2008) Use of anti-cyclic citrullinated peptide and anti-RA33 antibodies in diagnosing rheumatoid arthritis. Med Lab Sci Clin 19(3):84-85
113. Chen YH, Li SZ (2008) The diagnostic value of combined detection of anti-CCP antibody and rheumatoid factor in patients with rheumatoid arthritis. Lab Med Clin 5(18):1093-1094
114. Zeng HQ, Zhang DX, Yu HG, Dong HJ, Zhang XS (2008) Clinical value of combined tests of three antibodies assaies in the diagnosis of early stage for rheumatoid arthritis. Chin Gen Pract 11(4B):650-651
115. Li XL, Tao HQ, Zhang WH, Zheng YB (2006) The clinical application of Mark2 anti-cyclic citrullinated peptide determination in rheumatoid arthritis. Lab Med 21(6):599-601
116. Liang RC, Li YJ (2003) The detection of anti-cyclic citrullinated peptide antibody and the early diagnosis of rheumatoid arthritis. China J Mod Med 13(13):85-86
117. Chen BY, Deng HL, Yang WP (2008) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Lab Med Clin 5(18):1091-1093
118. Li XH, Zhang CJ (2009) Evaluation of anti-cyclic citrullinated peptide antibody, anti-keratin antibody and rheumatoid factor in diagnosis of early rheumatoid arthritis. China Med Herald 6(19):32-34
119. Zhou HQ, Xu XD, Zhang H, Dong M (2009) The comparison of anti-cyclic citrullinated peptide antibody and rheumatoid factor in rheumatoid arthritis diagnosis. Shenzhen J Integrat Chin West 19(4):224-226
120. Zhang RF, Jiang M (2009) Clinical application of anti-CCP antibody and AFA detection in diagnosis of rheumatoid arthritis. Qinghai Med J 39(4):1-3
121. Guo PE, Qin Q, Wu SM, Shen Q (2003) Clinical significance of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Jiangxi Med Lab Sci 21(5):331-332
122. Han YX, Shao FL, Liu FZ, Jin HT, Liu XL (2005) Diagnostic value of anti- cyclic citrullinated peptide antibody assay for rheumatoid arthritis. Clin Focus 20(22):1276-1278
123. Zhu HL (2006) Clinical value of the combined detection of anti-CCP antibody and RF in the diagnosis of rheumatoid arthritis. Mod Med Health 22(11):1593-1594
124. Li GF, Gao F, Wang L (2005) The diagnostic value anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Mod Lab Med 20(3):7-10
125. Zhao L, Ren SH, Hou AP (2009) Study on the anti-cyclic citrullinated peptide antibodies and the rheumatoid factors in the diagnosis of rheumatoid arthritis. China Pract Med 4(36):67-68
126. Zeng XF, Ai MX, Tian XP, Gan XD, Shi YP, Song QF et al (2003) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30(7):1451-1455
127. Li H, Song WQ, Li Y, Liu YH, Bai J, Li X et al (2010) Diagnostic value of anti-cyclic citrullinated peptide antibody in Northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29(4):413-417
128. Ge WL (2010) Clinical value of combined detection of serum anti-citrullinated peptide antibody (anti-CCP Ab) and rheumatoid factor (RF) in diagnosis of rheumatoid arthritis. J Radioimmumol 23(2):131-133
129. Zhang GQ, Chang LM, Fang XL (2010) Diagnostic value of the combined detection of anti-CCP antibody, anti-RA33 antibody and RF in rheumatoid arthritis. Chin J Clin Lab Sci 28(3):196-197
130. Guo DM, Zhang HW, Chen GQ (2009) The clinical value of anti- anti-citrullinated peptide antibody and rheumatoid factor combined detection in rheumatoid arthritis. PJCCPVD 17(12):1048-1049
131. He HJ, Qiu GB (2008) Clinical application of anti-CCP antibody in diagnosis of rheumatoid arthritis. Chins Med Herald 5(5):76
132. Hu ZD, Lv JQ, Yan BY, Xing N, Fu L, Wei G et al (2007) The value of anti-cyclic citrullinated peptide antibody and vascular endothelial growth factor in the diagnosis of rheumatoid arthritis. Lab Med 22(1):41-43
133. Xiao CH, Wu QF, Zhang LH, Yang SF, Li KQ (2006) Detection and significance of synovial fluid anti-CCP antibody in rheumatoid arthritis. Chin J Rheumatol 10(3):184-186
134. Wang JY, Li P, Wang WG (2006) Specific antibodies of the early diagnosis of rheumatoid arthritis. Chin J Diagn 10(12):1446-1448
135. Sun SJ (2004) Diagnostic value of detecting anti-cyclic cirtrullinated peptide antibody in rheumatoid arthritis. Acta Academiae Medicinae Militaris Tertiae 26(19):1786-1787
136. Zhao HC, Xiang GJ (2005) Clinical diagnostic value of combined determiantion of serum RF, AKA, and anti-CCP antibody levels in patients with rheumatoid arthritis. J Radioimmunol 18(6):501-503
137. Shi HY (2007) Clinical value of combined detection of anti-cyclic citrullinated peptide antibody and the rheumatoid factors in patients with rheumatoid arthritis. China Pract Med 2(2):116-117
138. Zhao X, Jiang H, Liu DJ (2006) Clinical diagnostic value of anti-CCP antibody levels in patients with rheumatoid arthritis. Heilongjiang Med J 30(8):637-638
139. Zhao YX, Zhang TH, Zhang JJ (2006) Clinical significance of RF, AKA, and anti-CCP antibody levels in patients with rheumatoid arthritis. Shaanxi Med J 35(3):335-336
140. Zhang JM, Mu Y, Jin M, Jin Y, Lv TH (2005) Detection and significance of the anti-CCP antibody, anti-RA54, anti-Sa antibody and rheumatoid factor in patients with rheumatoid arthritis. J Pract Diagn Therapy 19(2):81-83
141. Tan LM, Peng WH, Cao LP, Li H, Cai LL, Wang YY et al (2006) A study on anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. Jiangxi J Med Lab Sci 24(4):312-314
142. Sui XF, Chi WQ, Yao YH, Zhang CM, Jiang YH (2010) The significance of detecting anti-cyclic citrullianted peptide and rheumatoid factor in the earlier diagnosis of rheumatoid arthritis. Heilongjiang Med J 34(4):268-269
143. Kwok JSY, Hui KH, Lee TL, Wong W, Lau YL, Wong RWS et al (2005) Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 34:359-366
144. Mimori T (2005) Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med 44(11):1122-1126
145. Huang QS, Wan LQ, Luo ZQ, Le AP, Wang WQ (2006) Diagnostic value of anti-cyclic citrullinated peptide antibody for rheumatoid arthritis: a meta-analysis. Natl Med J China 86(31):2182-2187
146. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al (2007) Meta-analysis diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146(11):816-817
147. Liao KP, Batra KL, Chibnik L, Schur PH, Costenbader KH (2008) Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis 67(11):1557-1561